| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $7.2M | +47.1% |
| Cost of Revenue | $3.9M | +40.1% |
| Gross Profit | $3.3M | +56.4% |
| R&D Expense | $444K | +9.1% |
| SG&A Expense | $3.2M | -20.5% |
| Operating Income | -$1.3M | +62.4% |
| Pre-tax Income | -$2.1M | +46.8% |
| Income Tax | $2K | -60.0% |
| Net Income | -$2.1M | +46.8% |
| EPS (Basic) | -$0.01 | +50.0% |
| EPS (Diluted) | -$0.01 | +50.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $1.4M | +96.4% |
| Inventory | $984K | +10.6% |
| Current Assets | $2.6M | +46.7% |
| Total Assets | $3.2M | +17.6% |
| Current Liabilities | $10.9M | +32.3% |
| Total Liabilities | $11.1M | +30.6% |
| Stockholders' Equity | -$32.8M | -6.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.0M | -10.8% |
| Capital Expenditures | $80K | +90.5% |
| Investing Cash Flow | -$80K | -90.5% |
| Financing Cash Flow | $3.1M | +13.2% |
| Free Cash Flow | -$3.0M | -12.1% |